Cat.#: ACPP-1444
Despition | VAMP2 Human Recombinant |
SIZE | 5 µg |
Purity | > 95.0% (SDS-PAGE) |
Form | Sterile Filtered colorless solution. |
Storage | Store at 4°C for 2-4 weeks. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1078 | Glutamate Receptor 1 Blocking Peptide (AC1078) | 250 µg | inquiry |
ACPP-1594 | Human CCM2 Protein (AC1594) | 2 µg | inquiry |
ACPP-1260 | iNOS Blocking Peptide (AC1260) | 250 µg | inquiry |
ACPP-1024 | Recombinant Human FGF2 Protein (mutated Q65I + C96S + N111G). (AC1024) | 50 µg | inquiry |
ACPP-1403 | Human Insulin (Active) Protein (AC1403) | 1 mg | inquiry |
ACPP-1810 | Rat LIF Protein (AC1810) | 2 µg | inquiry |
ACPP-1076 | Synaptophysin Blocking Peptide (AC1076) | 250 µg | inquiry |
ACPP-1841 | Human DDAH1 Protein (AC1841) | 5 µg | inquiry |
ACPP-1226 | PDE7A Blocking Peptide (AC1226) | 250 µg | inquiry |
ACPP-1627 | Human Visfatin Protein, His (AC1627) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.